Magnetic logic device
    71.
    发明授权
    Magnetic logic device 失效
    磁逻辑器件

    公开(公告)号:US07652398B2

    公开(公告)日:2010-01-26

    申请号:US10536699

    申请日:2003-11-26

    CPC classification number: H03K19/18

    Abstract: A method for operating a magnetic logic device (10) is described wherein at least one output variable O=F (IA, IB) is formed from input variables (IA, IB) by at least one logic operation with an operator function F of the magnetic logic device (10), whereby the logic device (10) is set at a starting state for executing the operator function F with a certain operator control signal (SET) before the operation, whereby the operator control signal is selected from a group of control signals with which various non-volatile starting states can be set in a controlled manner, each state being characteristic of a different logic function. Furthermore, a magnetic logic device (10) equipped for implementation of this method is also described.

    Abstract translation: 描述了一种用于操作磁逻辑器件(10)的方法,其中至少一个输出变量O = F(IA,IB)由输入变量(IA,IB)由至少一个逻辑运算形成,其中运算符函数F为 磁逻辑器件(10),由此逻辑器件(10)被设置在用于在操作之前用一定的操作员控制信号(SET)执行操作功能F的起始状态,由此操作者控制信号从一组 可以以受控的方式设置各种非易失性起始状态的控制信号,每个状态是不同逻辑功能的特征。 此外,还描述了配备用于实现该方法的磁逻辑装置(10)。

    Microwave antenna for flip-chip semiconductor modules
    72.
    发明授权
    Microwave antenna for flip-chip semiconductor modules 有权
    用于倒装芯片半导体模块的微波天线

    公开(公告)号:US07612728B2

    公开(公告)日:2009-11-03

    申请号:US10593337

    申请日:2005-03-16

    Abstract: The invention relates to a microwave antenna for flip-chip semiconductor modules, comprising two semiconductor substrates which are metallized on the surface thereof. Patch antennas, i.e. metallized flat areas which are insulated from the rest of the circuit on an outer surface of a module with a supply line to the circuit, are already known per se. They result in vertical radiation at a relatively large angle. According to the invention, a closed group of bumps are arranged in such a way that the distance of the bumps (2) to each other is less than the half wavelength (λ/2) of the microsignal which is to be radiated or received and an open radiation slot arises in at least one pair of side walls (3,4) of the semiconductor substrates (a,b) and a bump, which is connected to the circuit of the semiconductor module, is arranged between the bumps (2) and the radiation slot, enabling the microwave antenna to be excited.

    Abstract translation: 本发明涉及一种用于倒装芯片半导体模块的微波天线,包括在其表面上金属化的两个半导体衬底。 贴片天线,即在电路的外表面与电路的其余部分绝缘的金属化平坦区域,其电路具有电源线,本身已经是已知的。 它们导致相对较大角度的垂直辐射。 根据本发明,封闭的凸块组被布置成使得凸块(2)彼此的距离小于要被辐射或接收的微信号的半波长(λ/ 2),并且 在半导体基板(a,b)的至少一对侧壁(3,4)中产生开放的辐射狭槽,并且连接到半导体模块的电路的凸块布置在凸块(2)之间, 和辐射槽,使微波天线得以激发。

    Magnetic logic device
    73.
    发明申请
    Magnetic logic device 失效
    磁逻辑器件

    公开(公告)号:US20060164124A1

    公开(公告)日:2006-07-27

    申请号:US10536699

    申请日:2003-11-26

    CPC classification number: H03K19/18

    Abstract: A method for operating a magnetic logic device (10) is described wherein at least one output variable O=F (IA, IB) is formed from input variables (IA, IB) by at least one logic operation with an operator function F of the magnetic logic device (10), whereby the logic device (10) is set at a starting state for executing the operator function F with a certain operator control signal (SET) before the operation, whereby the operator control signal is selected from a group of control signals with which various non-volatile starting states can be set in a controlled manner, each state being characteristic of a different logic function. Furthermore, a magnetic logic device (10) equipped for implementation of this method is also described.

    Abstract translation: 描述了一种用于操作磁逻辑器件(10)的方法,其中至少一个输出变量O = F(I A,I B B)由输入变量(I 通过具有磁逻辑器件(10)的操作器功能F的至少一个逻辑运算,由此将逻辑器件(10)设置在一个或多个逻辑器件(10) 用于在操作之前用一定的操作员控制信号(SET)执行操作功能F的起动状态,从而从可以以受控的方式设置各种非易失性起动状态的一组控制信号中选择操作员控制信号, 每个状态是不同逻辑功能的特征。 此外,还描述了配备用于实现该方法的磁逻辑装置(10)。

    1,2,4-triazole derivatives as tankyrase inhibitors

    公开(公告)号:US11926614B2

    公开(公告)日:2024-03-12

    申请号:US17253668

    申请日:2019-06-19

    Abstract: The present invention relates to compounds of formula (I), tautomers, stereoisomers, pharmaceutically acceptable salts and pro-drugs thereof, to processes for their preparation, to pharmaceutical compositions containing such compounds and to their use in therapy wherein a dashed line indicates an optional bond; X represents: a 5- or 6-membered, unsaturated heterocyclic group optionally substituted by one or more (e.g. 1, 2 or 3) substituents independently selected from halogen (i.e. F, Cl, Br, I), C1-6 alkyl (e.g. C1-3 alkyl), C1-6 haloalkyl (e.g. C1-3 haloalkyl), C1-6 alkoxy (e.g. C1-3 alkoxy), —CN, —NO2, —N(R)2, and —SO2R (where each R is independently H or C1-6 alkyl, e.g. H or C1-3 alkyl); a C3-5 cycloalkyl group optionally substituted by one or more (e.g. 1 or 2) substituents independently selected from C1-6 alkyl (preferably C1-3 alkyl), C1-6 haloalkyl (e.g. C1-3 haloalkyl), and C1-6 alkoxy (e.g. C1-3 alkoxy); or an aryl group optionally substituted by one or more (e.g. 1, 2 or 3) substituents independently selected from halogen (i.e. F, Cl, Br, I), C1-6 alkyl (e.g C1-3 alkyl), C1-6 haloalkyl (e.g. C1-3 haloalkyl), and C1-6 alkoxy (e.g. C1-3 alkoxy); Y represents: an aryl or heteroaryl group optionally substituted by one or more (e.g. 1, 2 or 3) substituents independently selected from halogen (i.e. F, Cl, Br, I), C1-6 alkyl (e.g C1-3 alkyl), C1-6 haloalkyl (e.g. C1-3 haloalkyl), and C1-6 alkoxy (e.g. C1-3 alkoxy); a 5- or 6-membered, saturated heterocyclic group optionally substituted by one or more (e.g. 1, 2 or 3) substituents independently selected from C1-6 alkyl (preferably C1-3 alkyl), C1-6 haloalkyl (e.g. C1-3 haloalkyl), and C1-6 alkoxy (e.g. C1-3 alkoxy); or a C3-6 cycloalkyl group optionally substituted by one or more (e.g. 1 or 2) substituents independently selected from C1-6 alkyl (preferably C1-3 alkyl), C1-6 haloalkyl (e.g. C1-3 haloalkyl), and C1-6 alkoxy (e.g. C1-3 alkoxy); and Z represents: an aryl group optionally substituted by one or more (e.g. 1, 2 or 3) substituents independently selected from halogen (i.e. F, Cl, Br, I), C1-6 alkyl (e.g. C1-3 alkyl), C1-6 haloalkyl (e.g. C1-3 haloalkyl), C1-6 alkoxy (e.g. C1-3 alkoxy), —CN, —NO2, —N(R)2, and —SO2R (where each R is independently H or C1-6 alkyl, e.g. H or C1-3 alkyl); or an unsaturated, 5- to 10-membered mono- or bicyclic heterocyclic group optionally substituted by one or more (e.g. 1, 2 or 3) substituents independently selected from halogen (i.e. F, Cl, Br, I), C1-6 alkyl (e.g. C1-3 alkyl), C1-6 haloalkyl (e.g. C1-3 haloalkyl), C1-6 alkoxy (e.g. C1-3 alkoxy), —CN, —NO2, —N(R)2, and —SO2R (where each R is independently H or C1-6 alkyl, e.g. H or C1-3 alkyl). These compounds find particular use in the treatment and/or prevention of a disease or disorder responsive to inhibition of tankyrase 1 and/or 2, for example a disorder which is mediated by tankyrase 1 and/or 2 such as cancer.

Patent Agency Ranking